-
Mashup Score: 1
Online resources about liquid biopsies have several deficits that could prevent patients from learning about the test and better understanding , according to findings published in JAMA Network Open.ideos often lack diversity, can be complex and have lowquality wh web pages have readability scores equivalent to college-level education.
Source: www.healio.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2
Sumanta K. Pal, MD, FASCO, expressed a mix of emotions.CTX130 (CRISPR Therapeutics), an investigational CD70-targeted allogeneic chimeric antigen receptor T-cell therapy, produced promising results in a phase 1 trial for patients with advanced clear-cell renal cell carcinoma (RCC)
Source: www.healio.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 8More than 25% of cancer survivors report mobility disability - 3 day(s) ago
More than one-fourth of cancer survivors reported having a physical disability that diminished their mobility, according to study results published in Journal of Clinical Oncology.Nearly 10% reported a disability that impacted self-care, findings showed.
Source: www.healio.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Vitamin A before stem cell transplant ‘potentially practice changing’ to lower GVHD risk - 3 day(s) ago
High-dose oral vitamin A prior to hematopoietic stem cell transplantation reduced the incidence of graft-versus-host disease with minimal toxicity, according to study data published in Blood.Results from a randomized phase 2 trial showed improvements in both the incidence of acute graft-versus-host disease (GVHD) and acute gastrointestinal (GI) GVHD 180 days or more after transplant compared with
Source: www.healio.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
Exagamglogene autotemcel gave most patients with beta-thalassemia transfusion independence and drastically reduced the number of vaso-occlusive crises in those with sickle cell disease in a pair of phase 3 trials.More than 90% of participants in each trial met researchers’ primary endpoints, according final study data published in The New England Journal of Medicine.
Source: www.healio.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
Individuals with low-risk chronic lymphocytic leukemia who exhibit no symptoms may no longer require specialized follow-up, according to study data published in Blood Advances.The findings show that among asymptomatic patients with CLL, those who discontinued physician follow-up had fewer hospital visits and fewer infections, while also having similar 3-year survival rates compared with patients
Source: www.healio.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Daily aspirin use did not reduce disease recurrence, progression or mortality in patients with high-risk breast cancer, according to extended follow-up results of a terminated study published in JAMA.Researchers examined more than 3,000 individuals in the phase 3 randomized trial, and those in the aspirin cohort had a higher number of invasive DFS events, although the authors determined the
Source: www.healio.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Compared with standard-of-care chemotherapy, trastuzumab deruxtecan demonstrated a statistically significant improvement in PFS among certain patients with metastatic breast cancer, according to a press release from the manufacturer. Trastuzumab deruxtecan (Enhertu; AstraZeneca, Daiichi Sankyo) is a HER2-directed antibody-drug conjugate consisting of a HER2 monoclonal antibody attached to a
Source: www.healio.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Aspirin may have ‘direct role’ in augmenting the immune system to fight colorectal cancer - 16 day(s) ago
Whereas previous studies have shown aspirin use decreases incidence and mortality of colorectal cancer, researchers may now have insight into why this occurs, according to study results published in Cancer.Individuals who used aspirin had fewer nodal metastases and increased tumor-infiltrating lymphocyte penetration, and expressed more proteins to help the body ward off the disease in the
Source: www.healio.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0FDA approves Anktiva for certain patients with bladder cancer - 16 day(s) ago
The FDA approved nogapendekin alfa inbakicept-pmln plus Bacillus Calmette-Guerin for the treatment of certain patients with bladder cancer, according to a press release from the manufacturer.The indication applies to individuals with Bacillus Calmette-Guerin (BCG) unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ.
Source: www.healio.comCategories: General Medicine News, Onc News and JournalsTweet
Online resources about liquid biopsies have several deficits that could prevent patients from learning about the tests and better understanding them, according to data published in @JAMANetworkOpen. Read more👇 https://t.co/AlxiG0BnNg